KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Dividends Paid - Common: 2016-2018

Historic Dividends Paid - Common for Amneal Pharmaceuticals (AMRX) over the last 3 years, with Dec 2018 value amounting to $183.0 million.

  • Amneal Pharmaceuticals' Dividends Paid - Common fell 99.99% to $2,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $203.0 million, marking a year-over-year change of. This contributed to the annual value of $183.0 million for FY2018, which is 51.23% down from last year.
  • As of FY2018, Amneal Pharmaceuticals' Dividends Paid - Common stood at $183.0 million, which was down 51.23% from $375.3 million recorded in FY2017.
  • Amneal Pharmaceuticals' 5-year Dividends Paid - Common high stood at $375.3 million for FY2017, and its period low was $183.0 million during FY2018.
  • Over the past 3 years, Amneal Pharmaceuticals' median Dividends Paid - Common value was $200.6 million (recorded in 2016), while the average stood at $253.0 million.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first spiked by 87.06% in 2017, then plummeted by 51.23% in 2018.
  • Over the past 3 years, Amneal Pharmaceuticals' Dividends Paid - Common (Yearly) stood at $200.6 million in 2016, then surged by 87.06% to $375.3 million in 2017, then tumbled by 51.23% to $183.0 million in 2018.